CTLA-4

ESMO 2023: A new immunotherapy, volrustomig, for the first-line treatment of advanced kidney cancer

By Sharon Deveson Kell|2023-10-31T09:16:21+00:0031 Oct 2023|Drug treatments|

Blocking the action of two proteins in cancer cells (PD-1 [...]

Comments Off

PD-1 and CTLA-4 as biomarkers for survival in kidney cancer

By Sharon Kell|2019-06-24T08:28:24+00:0024 Jun 2019|Cancer news|

A recent study published in Journal of Clinical Medicine last [...]

Comments Off

Address

Action Kidney Cancer

11th Floor
3 Piccadilly Place
Manchester M1 3BN

Helpline

0800 121 8721
Email Us

About Action Kidney Cancer

We are the UK’s largest and most active patient-led kidney cancer charity. Whether you are a patient, survivor or someone you know has been diagnosed with kidney cancer, you have come to the right place to find support and information, and to be part of a caring and knowledgeable community of people: We are here to help you.

Registered charity in England, Wales (1164238), and Scotland (SC051330).

© Copyright Action Kidney Cancer 2021

Links

Branding by Kingswood Marketing

Policies

Website Policies

Complaints Policy

Equal Opportunities Policy

Information Governance Policy

Social Media Policy

Health Information Policy

Follow

Web Design by Douglass Digital

Helpline: 0800 121 8721

support@actionkidneycancer.org